Association	O
between	O
neutrophil	B:C0027950
-	O
to	O
-	O
lymphocyte	O
ratio	O
and	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
:	O
a	O
meta-analysis	O
.	O

Association	O
between	O
neutrophil	O
-	O
to	O
-	O
lymphocyte	B:C0024264
ratio	O
and	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
:	O
a	O
meta-analysis	O
.	O

Association	O
between	O
neutrophil	O
-	O
to	O
-	O
lymphocyte	O
ratio	O
and	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
:	O
a	O
meta-analysis	O
.	O

Association	O
between	O
neutrophil	O
-	O
to	O
-	O
lymphocyte	O
ratio	O
and	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
:	O
a	O
meta-analysis	B:C0920317
.	O

The	O
association	O
between	O
neutrophil	B:C0027950
-	O
to-	O
lymphocyte	O
ratio	O
(	O
NLR	O
)	O
and	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
(	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
)	O
is	O
undecided	O
.	O

The	O
association	O
between	O
neutrophil	O
-	O
to-	O
lymphocyte	B:C0024264
ratio	O
(	O
NLR	O
)	O
and	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
(	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
)	O
is	O
undecided	O
.	O

The	O
association	O
between	O
neutrophil	O
-	O
to-	O
lymphocyte	O
ratio	O
(	O
NLR	O
)	O
and	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
(	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
)	O
is	O
undecided	O
.	O

The	O
association	O
between	O
neutrophil	O
-	O
to-	O
lymphocyte	O
ratio	O
(	O
NLR	O
)	O
and	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
(	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
)	O
is	O
undecided	O
.	O

To	O
rectify	O
this	O
question	O
,	O
we	O
conducted	O
a	O
systematic	O
meta-	B:C0920317
analysis	I:C0920317
based	O
on	O
7	O
prospective	O
cohort	I:C0033522
studies	I:C0033522
published	O
between	O
2013	O
and	O
2015	O
,	O
comprising	O
7349	O
patients	O
.	O

To	O
rectify	O
this	O
question	O
,	O
we	O
conducted	O
a	O
systematic	O
meta-	O
analysis	I:C0920317
based	O
on	O
7	O
prospective	B:C0033522
cohort	I:C0033522
studies	I:C0033522
published	O
between	O
2013	O
and	O
2015	O
,	O
comprising	O
7349	O
patients	O
.	O

To	O
rectify	O
this	O
question	O
,	O
we	O
conducted	O
a	O
systematic	O
meta-	O
analysis	I:C0920317
based	O
on	O
7	O
prospective	O
cohort	I:C0033522
studies	I:C0033522
published	B:C1704324
between	O
2013	O
and	O
2015	O
,	O
comprising	O
7349	O
patients	O
.	O

Six	O
of	O
these	O
cohorts	B:C0599755
included	O
pretreatment	O
(	O
baseline	O
)	O
NLR	O
data	O
for	O
patients	O
with	O
thyroid	O
nodules	I:C0040137
.	O

Six	O
of	O
these	O
cohorts	O
included	O
pretreatment	O
(	O
baseline	O
)	O
NLR	O
data	O
for	O
patients	O
with	O
thyroid	B:C0040137
nodules	I:C0040137
.	O

The	O
meta	B:C0920317
-analysis	I:C0920317
of	O
these	O
6	O
cohorts	O
showed	O
that	O
the	O
NLR	O
of	O
patients	O
with	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
(	O
4617	O
cases	O
)	O
was	O
statistically	O
similar	O
to	O
patients	O
with	O
benign	O
nodules	I:C0749467
only	O
(	O
1666	O
cases	O
)	O
,	O
with	O
a	O
mean	O
difference	O
(	O
MD	O
)	O
of	O
0.19	O
(	O
95	O
%	O
CI	O
:	O
-	O
0.09	O
to	O
0.46	O
;	O
I	O
(	O
2	O
)	O
=	O
93	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

The	O
meta	O
-analysis	I:C0920317
of	O
these	O
6	O
cohorts	B:C0599755
showed	O
that	O
the	O
NLR	O
of	O
patients	O
with	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
(	O
4617	O
cases	O
)	O
was	O
statistically	O
similar	O
to	O
patients	O
with	O
benign	O
nodules	I:C0749467
only	O
(	O
1666	O
cases	O
)	O
,	O
with	O
a	O
mean	O
difference	O
(	O
MD	O
)	O
of	O
0.19	O
(	O
95	O
%	O
CI	O
:	O
-	O
0.09	O
to	O
0.46	O
;	O
I	O
(	O
2	O
)	O
=	O
93	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

The	O
meta	O
-analysis	I:C0920317
of	O
these	O
6	O
cohorts	O
showed	O
that	O
the	O
NLR	O
of	O
patients	O
with	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
(	O
4617	O
cases	O
)	O
was	O
statistically	O
similar	O
to	O
patients	O
with	O
benign	O
nodules	I:C0749467
only	O
(	O
1666	O
cases	O
)	O
,	O
with	O
a	O
mean	O
difference	O
(	O
MD	O
)	O
of	O
0.19	O
(	O
95	O
%	O
CI	O
:	O
-	O
0.09	O
to	O
0.46	O
;	O
I	O
(	O
2	O
)	O
=	O
93	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

The	O
meta	O
-analysis	I:C0920317
of	O
these	O
6	O
cohorts	O
showed	O
that	O
the	O
NLR	O
of	O
patients	O
with	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
(	O
4617	O
cases	O
)	O
was	O
statistically	O
similar	O
to	O
patients	O
with	O
benign	B:C0749467
nodules	I:C0749467
only	O
(	O
1666	O
cases	O
)	O
,	O
with	O
a	O
mean	O
difference	O
(	O
MD	O
)	O
of	O
0.19	O
(	O
95	O
%	O
CI	O
:	O
-	O
0.09	O
to	O
0.46	O
;	O
I	O
(	O
2	O
)	O
=	O
93	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

No	O
significant	O
difference	O
in	O
NLR	O
was	O
found	O
between	O
patients	O
with	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
and	O
patients	O
with	O
benign	O
nodules	I:C0749467
.	O

No	O
significant	O
difference	O
in	O
NLR	O
was	O
found	O
between	O
patients	O
with	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
and	O
patients	O
with	O
benign	B:C0749467
nodules	I:C0749467
.	O

Two	O
studies	B:C0947630
addressed	O
an	O
association	O
between	O
NLR	O
and	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
in	O
patients	O
stratified	O
by	O
age	O
<	O
45	O
and	O
≥	O
45	O
years	O
(	O
496	O
and	O
891	O
cases	O
,	O
respectively	O
)	O
;	O
the	O
pooled	O
MD	O
was	O
0.09	O
(	O
95	O
%	O
CI	O
:	O
-	O
0.37	O
to	O
0.55	O
;	O
I	O
(	O
2	O
)	O
=	O
92.2	O
%	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Two	O
studies	O
addressed	O
an	O
association	O
between	O
NLR	O
and	O
papillary	B:C0238463
thyroid	I:C0238463
carcinoma	I:C0238463
in	O
patients	O
stratified	O
by	O
age	O
<	O
45	O
and	O
≥	O
45	O
years	O
(	O
496	O
and	O
891	O
cases	O
,	O
respectively	O
)	O
;	O
the	O
pooled	O
MD	O
was	O
0.09	O
(	O
95	O
%	O
CI	O
:	O
-	O
0.37	O
to	O
0.55	O
;	O
I	O
(	O
2	O
)	O
=	O
92.2	O
%	O
,	O
P	O
<	O
0.001	O
)	O
.	O

An	O
elevated	O
NLR	O
seems	O
not	O
a	O
reliable	O
indicator	O
of	O
progressing	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
in	O
patients	O
with	O
goiters	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
NLR	O
between	O
patients	O
aged	O
<	O
45	O
years	O
and	O
those	O
aged	O
≥	O
45	O
years	O
.	O

An	O
elevated	O
NLR	O
seems	O
not	O
a	O
reliable	O
indicator	O
of	O
progressing	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
in	O
patients	O
with	O
goiters	B:C0018021
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
NLR	O
between	O
patients	O
aged	O
<	O
45	O
years	O
and	O
those	O
aged	O
≥	O
45	O
years	O
.	O

Well	O
-	O
designed	O
and	O
large	O
-	O
scale	O
investigations	B:C0220825
are	O
warranted	O
to	O
understand	O
the	O
value	O
of	O
NLR	O
in	O
the	O
prognosis	O
of	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
.	O

Well	O
-	O
designed	O
and	O
large	O
-	O
scale	O
investigations	O
are	O
warranted	O
to	O
understand	O
the	O
value	O
of	O
NLR	O
in	O
the	O
prognosis	B:C0011900
of	O
differentiated	O
thyroid	I:C1337013
cancer	I:C1337013
.	O

Well	O
-	O
designed	O
and	O
large	O
-	O
scale	O
investigations	O
are	O
warranted	O
to	O
understand	O
the	O
value	O
of	O
NLR	O
in	O
the	O
prognosis	O
of	O
differentiated	B:C1337013
thyroid	I:C1337013
cancer	I:C1337013
.	O

